MicroRNA Sponges: Competitive Inhibitors of Small RNAs in Mammalian Cells

Overview

Journal Nat Methods

Specialties Biomedical Engineering
Pathology

Date 2007 Aug 19

PMID 17694064

Citations 1040

Authors

Margaret S Ebert

Joel R Neilson

Phillip A Sharp

Affiliations

Soon will be listed here.

Abstract

MicroRNAs are predicted to regulate thousands of mammalian genes, but relatively few targets have been experimentally validated and few microRNA loss-of-function phenotypes have been assigned. As an alternative to chemically modified antisense oligonucleotides, we developed microRNA inhibitors that can be expressed in cells, as RNAs produced from transgenes. Termed 'microRNA sponges', these competitive inhibitors are transcripts expressed from strong promoters, containing multiple, tandem binding sites to a microRNA of interest. When vectors encoding these sponges are transiently transfected into cultured cells, sponges derepress microRNA targets at least as strongly as chemically modified antisense oligonucleotides. They specifically inhibit microRNAs with a complementary heptameric seed, such that a single sponge can be used to block an entire microRNA seed family. RNA polymerase II promoter (Pol II)-driven sponges contain a fluorescence reporter gene for identification and sorting of sponge-treated cells. We envision the use of stably expressed sponges in animal models of disease and development.

Citing Articles

Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer.

Ye C, Liu Z, Xie Q, Tang Y, Zeng J, Feng Z Front Oncol. 2025; 15:1443571.

PMID: 39959665 PMC: 11827427. DOI: 10.3389/fonc.2025.1443571.

Epigenetic regulation in coronary artery disease: from mechanisms to emerging therapies.

Gao R, Liu M, Yang H, Shen Y, Xia N Front Mol Biosci. 2025; 12:1548355.

PMID: 39959304 PMC: 11825346. DOI: 10.3389/fmolb.2025.1548355.

Modulating gene expression as a strategy to investigate thyroid cancer biology.

de Mello D, Menezes J, de Oliveira A, Cristovao M, Kimura E, Fuziwara C Arch Endocrinol Metab. 2025; 68(Spec Issue):e240073.

PMID: 39876973 PMC: 11771757. DOI: 10.20945/2359-4292-2024-0073.

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis.

Zhang Y, Yao R, Li M, Fang C, Feng K, Chen X Mol Cancer. 2025; 24(1):32.

PMID: 39871338 PMC: 11771119. DOI: 10.1186/s12943-024-02224-3.

MiRNAs as major players in brain health and disease: current knowledge and future perspectives.

Kapplingattu S, Bhattacharya S, Adlakha Y Cell Death Discov. 2025; 11(1):7.

PMID: 39805813 PMC: 11729916. DOI: 10.1038/s41420-024-02283-x.

References

Doench J, Sharp P . Specificity of microRNA target selection in translational repression. Genes Dev. 2004; 18(5):504-11. PMC: 374233. DOI: 10.1101/gad.1184404. View

Hutvagner G, Simard M, Mello C, Zamore P . Sequence-specific inhibition of small RNA function. PLoS Biol. 2004; 2(4):E98. PMC: 350664. DOI: 10.1371/journal.pbio.0020098. View

ODonnell K, Wentzel E, Zeller K, Dang C, Mendell J . c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005; 435(7043):839-43. DOI: 10.1038/nature03677. View

Davis S, Lollo B, Freier S, Esau C . Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 2006; 34(8):2294-304. PMC: 1459537. DOI: 10.1093/nar/gkl183. View

Neilson J, Zheng G, Burge C, Sharp P . Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 2007; 21(5):578-89. PMC: 1820899. DOI: 10.1101/gad.1522907. View

Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb J, Peck D . MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043):834-8. DOI: 10.1038/nature03702. View

Lewis B, Shih I, Jones-Rhoades M, Bartel D, Burge C . Prediction of mammalian microRNA targets. Cell. 2003; 115(7):787-98. DOI: 10.1016/s0092-8674(03)01018-3. View

Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P . MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007; 13(5):613-8. DOI: 10.1038/nm1582. View

Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I . MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res. 2004; 14(12):2486-94. PMC: 534673. DOI: 10.1101/gr.2845604. View

10.

Paul C, Good P, Li S, Kleihauer A, Rossi J, Engelke D . Localized expression of small RNA inhibitors in human cells. Mol Ther. 2003; 7(2):237-47. DOI: 10.1016/s1525-0016(02)00038-2. View

11.

John B, Enright A, Aravin A, Tuschl T, Sander C, Marks D . Human MicroRNA targets. PLoS Biol. 2004; 2(11):e363. PMC: 521178. DOI: 10.1371/journal.pbio.0020363. View

12.

Cheng H, Papp J, Varlamova O, Dziema H, Russell B, Curfman J . microRNA modulation of circadian-clock period and entrainment. Neuron. 2007; 54(5):813-29. PMC: 2590749. DOI: 10.1016/j.neuron.2007.05.017. View

13.

Doench J, Petersen C, Sharp P . siRNAs can function as miRNAs. Genes Dev. 2003; 17(4):438-42. PMC: 195999. DOI: 10.1101/gad.1064703. View

14.

Meister G, Landthaler M, Dorsett Y, Tuschl T . Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA. 2004; 10(3):544-50. PMC: 1370948. DOI: 10.1261/rna.5235104. View

15.

He L, Thomson J, Hemann M, Hernando-Monge E, Mu D, Goodson S . A microRNA polycistron as a potential human oncogene. Nature. 2005; 435(7043):828-33. PMC: 4599349. DOI: 10.1038/nature03552. View

16.

Krutzfeldt J, Rajewsky N, Braich R, Rajeev K, Tuschl T, Manoharan M . Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005; 438(7068):685-9. DOI: 10.1038/nature04303. View

17.

Orom U, Kauppinen S, Lund A . LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene. 2006; 372:137-41. DOI: 10.1016/j.gene.2005.12.031. View

18.

Chang T, Wentzel E, Kent O, Ramachandran K, Mullendore M, Lee K . Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007; 26(5):745-52. PMC: 1939978. DOI: 10.1016/j.molcel.2007.05.010. View

19.

Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

20.

Li Q, Chau J, Ebert P, Sylvester G, Min H, Liu G . miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007; 129(1):147-61. DOI: 10.1016/j.cell.2007.03.008. View